Alternative titles; symbols
SNOMEDCT: 237961001; ORPHA: 79314; DO: 0050574;
| Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
Gene/Locus |
Gene/Locus MIM number |
|---|---|---|---|---|---|---|
| 14q21.3 | L-2-hydroxyglutaric aciduria | 236792 | Autosomal recessive | 3 | L2HGDH | 609584 |
A number sign (#) is used with this entry because L-2-hydroxyglutaric aciduria (L2HGA) is caused by homozygous or compound heterozygous mutation in the L2HGDH gene (609584) on chromosome 14q21.
Duran et al. (1980) reported a 5-year-old boy of Moroccan (Berber) origin who was investigated for nonspecific mental and motor delay and growth deficiency. The point of interest was a solitary, large, and persistent increase of L-2-hydroxyglutaric (2OHglu) acid in the urine. Barth et al. (1992) reported on a total of 8 mentally retarded patients from 5 unrelated families, including 3 pairs of sibs. Four patients were male and 4 female. L-2-hydroxyglutaric acid concentration was also found to be increased in the cerebrospinal fluid and to a lesser extent in plasma. Lysine was also increased in plasma and CSF. Onset of symptoms was in childhood, and definite cerebellar dysfunction was identified in 7. In all patients, magnetic resonance imaging (MRI) revealed an identical abnormal pattern with subcortical leukoencephalopathy, cerebellar atrophy, and signal changes in the putamina and dentate nuclei. No specific biochemical function or catabolic pathway involving L-2-hydroxyglutaric acid was known in mammals, including humans. Preliminary loading and dietary studies failed to reveal the origin of the compound. One of the 2 families from Turkey had consanguineous parents and 2 affected children.
Wilcken et al. (1993) reported 3 cases from Australia, and Divry et al. (1993) reported 2 other cases. Two of the patients reported by Wilcken et al. (1993) were sisters born to fourth-cousin parents. One of the patients of Divry et al. (1993) was a Tunisian boy born to consanguineous parents. Macrocephaly, cerebellar signs, and abnormalities suggesting leukodystrophy on CT or MRI were diagnostic clues, all of which suggest that urinary analysis for organic acids is indicated.
Fujitake et al. (1999) described L-2-hydroxyglutaric aciduria in 2 adult Japanese sisters, both of whom were much older (aged 57 and 47 years) than previously reported patients. MRI showed typical subcortical white matter lesions in both patients and brainstem atrophy and thickness of the calvarium in the elder sister. L-2-hydroxyglutaric acid levels were increased in urine, plasma, and CSF. The parents were not related and had no neurologic symptoms; the patients' 6 sibs also lacked neurologic symptoms. The elder sister had generalized tonic-clonic seizure and was found to have psychomotor retardation in childhood. Her mental and motor impairments were slowly progressive, especially after 25 years of age; she became unable to walk at the age of 46 years. The younger sister seemed normal until the age of 3 years, when she became unable to walk for 3 months after her first seizure. She was thought to have mild psychomotor impairment at school age but was able to work as an assistant in her father's factory after graduation from elementary school. At the age of 41 years, upon admission to another hospital for surgery of an atrial septal defect, she was found to have nocturnal myoclonus. Neurologic examination disclosed mild mental retardation and cerebellar speech, horizontal nystagmus and saccadic eye movement, dystonia of the right arm, mild limb and truncal ataxia, and ataxic gait. Her deep tendon reflexes were hyperactive. Manifestations were slowly progressive over the next 6 years.
Seijo-Martinez et al. (2005) reported a 15-year-old Spanish boy with L-2-hydroxyglutaric aciduria. He was wheelchair-bound and had severe mental retardation, epilepsy, bilateral optic atrophy, strabismus, hypoacusis, spastic tetraparesis, and choreodystonia of the upper limbs. He died suddenly of massive mesenteric thrombosis. Neuropathologic examination showed mild cortical neuronal loss with intense gliosis, spongiosis, and vacuolation of the neuropil. The subcortical white matter contained numerous hyperplastic astrocytes and was severely demyelinated with cystic cavities consistent with imaging results. The basal ganglia and cerebellum were less affected, with only mild neuronal loss and no cavitations; however, spongiosis was present. Cranial nerve nuclei were not affected. Seijo-Martinez et al. (2005) noted that Canavan disease (271900) should be the major consideration in differential diagnosis.
Aghili et al. (2009) reported a 17-year-old boy with L-2-hydroxyglutaric aciduria who developed an anaplastic ependymoma during the course of his disease. A literature review identified 7 other patients with L-2-hydroxyglutaric aciduria who developed brain tumors, suggesting an increased risk of brain tumors in this patient population.
Suhs et al. (2012) reported a 24-year-old woman with late-onset L-2-hydroxyglutaric aciduria symptoms manifest as progressive and disabling cerebellar tremor. Her mother reported delayed psychomotor development in childhood and worked in a commercial kitchen. Physical examination of the patient showed intention tremor, action-induced negative myoclonus, slow horizontal saccades, and a hypokinetic syndrome. Brain MRI showed T2-weighted hyperintensities in the supratentorial white matter, most pronounced around the frontal and parietal lobes. No signal abnormalities were seen in the basal ganglia or cerebellum. MR spectroscopy showed a reduced choline peak, compatible with myelin degeneration. Suspicion of a metabolic disorder yielded studies that revealed increased urinary L-2-hydroxyglutaric acid and increased plasma values of lysine, isoleucine, leucine, valine, and cystine. Genetic analysis confirmed the diagnosis. The patient was put on a low lysine diet and showed clinical and biochemical improvement, although the MRI did not change.
Topcu et al. (2004) mapped the disorder to chromosome 14q22.1 by homozygosity mapping.
Rzem et al. (2004) demonstrated that L-2-hydroxyglutarate is normally metabolized to alpha-ketoglutarate (a compound amply provided by other sources) and concluded that the pathologic findings in this metabolic disorder are due to a toxic effect of L-2-hydroxyglutarate on the central nervous system.
The transmission pattern of L2HGA in the families reported by Topcu et al. (2004) was consistent with autosomal recessive inheritance.
In 21 patients with L-2-hydroxyglutaric aciduria (L2HGA) from 15 Turkish families, 14 of them consanguineous, Topcu et al. (2004) found 9 mutations in the L2HGDH gene (see, e.g., 609584.0001-609584.0005). The 9 mutations comprised 3 missense mutations, 2 nonsense mutations, 2 splice site mutations, and 2 deletions. The gene encodes a putative mitochondrial protein, which the authors dubbed 'duranin,' with homology to FAD-dependent oxidoreductases.
In 3 consanguineous families with L-2-hydroxyglutaric aciduria, of Belgian, Tunisian, and Lebanese origin, respectively, Rzem et al. (2004) identified homozygosity for 3 different mutations in the L2HGDH gene that cosegregated with the disease in each family.
Najmabadi et al. (2011) performed homozygosity mapping followed by exon enrichment and next-generation sequencing in 136 consanguineous families (over 90% Iranian and less than 10% Turkish or Arab) segregating syndromic or nonsyndromic forms of autosomal recessive intellectual disability. In a family (8600276) in which 4 of 7 children had L-2-hydroxyglutaric aciduria and profound intellectual disability and were unable to walk, Najmabadi et al. (2011) identified homozygosity for a nonsense mutation in the L2HGDH gene (609584.0007) in all of those affected. The parents were distantly related.
Canine Model
Penderis et al. (2007) described a spontaneous canine model of L-2-hydroxyglutaric aciduria in outbred Staffordshire bull terriers. Twenty-one affected dogs all showed increased urinary 2-HG and 12 dogs in whom MRI imaging was done showed symmetric regions of hyperintensity similar to that seen in humans with the disorder. Homozygosity mapping and direct sequencing identified a homozygous mutation in exon 10 of the canine L2hgdh gene in all affected animals. Pedigree analysis indicated a founder effect.
Mouse Model
Ma et al. (2017) observed age-dependent accumulation of L-2-hydroxyglutarate in cerebrum and alterations in a subset of histone methylations in the central nervous system of L2hgdh -/- mice. Mutant mice exhibited subcortical white matter abnormalities, recapitulating clinical features of patients with L-2-hydroxyglutaric aciduria. L2hgdh mice also showed dys/demyelination, extensive gliosis, expanded oligodendrocyte progenitor cell numbers, and microglia-mediated neuroinflammation. Additionally, L2hgdh -/- mice had impaired adult hippocampal neurogenesis, as well as age-dependent neurodegeneration.
Feline Model
Christen et al. (2021) described a 7-month-old cat with L-2-hydroxyglutaric aciduria. The cat developed paroxysmal seizure-like episodes and hallucination-type episodes at 3 months of age. Between seizure episodes, the neurologic exam was normal except for absence of a bilateral menace response. A brain MRI demonstrated multifocal, symmetric hyperintensities in the diencephalon, mesencephalon, and metencephalon primarily affecting gray matter. Urine organic acid testing identified increased L-2-hydroxyglutaric acid. Whole-genome sequencing followed by Sanger sequencing confirmation showed homozygosity for a c.1301A-G transition (XM_023255678.1) in the L2HGDH gene, resulting in a his434-to-arg substitution. The mutation was not identified in 48 control cat genomes. The affected cat was treated with keppra and phenobarbital, which successfully managed the seizures.
Aghili, M., Zahedi, F., Rafiee, E. Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review. J. Neurooncol. 91: 233-236, 2009. [PubMed: 18931888] [Full Text: https://doi.org/10.1007/s11060-008-9706-2]
Barth, P. G., Hoffmann, G. F., Jaeken, J., Lehnert, W., Hanefeld, F., van Gennip, A. H., Duran, M., Valk, J., Schutgens, R. B. H., Trefz, F. K., Reimann, G., Hartung, H.-P. L-2-hydroxyglutaric acidemia: a novel inherited neurometabolic disease. Ann. Neurol. 32: 66-71, 1992. [PubMed: 1642474] [Full Text: https://doi.org/10.1002/ana.410320111]
Christen, M., Janzen, N., Fraser, A., Sewell, A. C., Jagannathan, V., Guevar, J., Leeb, T., Sanchez-Masian, D. L2HGDH missense variant in a cat with L-2-hydroxyglutaric aciduria. Genes 12: 682, 2021. [PubMed: 34062805] [Full Text: https://doi.org/10.3390/genes12050682]
Divry, P., Jakobs, C., Vianey-Saban, C., Gibson, K. M., Michelakakis, H., Papadimitriou, A., Divari, R., Chabrol, B., Cournelle, M. A., Livet, M. O. L-2-hydroxyglutaric aciduria: two further cases. J. Inherit. Metab. Dis. 16: 505-507, 1993. [PubMed: 7609438] [Full Text: https://doi.org/10.1007/BF00711666]
Duran, M., Kamerling, J. P., Bakker, H. D., van Gennip, A. H., Wadman, S. K. L-2-hydroxyglutaric aciduria: an inborn error of metabolism? J. Inherit. Metab. Dis. 3: 109-112, 1980. [PubMed: 6787330] [Full Text: https://doi.org/10.1007/BF02312543]
Fujitake, J., Ishikawa, Y., Fujii, H., Nishimura, K., Hayakawa, K., Inoue, F., Terada, N., Okochi, M., Tatsuoka, Y. L-2-hydroxyglutaric aciduria: two Japanese adult cases in one family. J. Neurol. 246: 378-382, 1999. [PubMed: 10399870] [Full Text: https://doi.org/10.1007/s004150050367]
Ma, S., Sun, R., Jiang, B., Gao, J., Deng, W., Liu, P., He, R., Cui, J., Ji, M., Yi, W., Yang, P., Wu, X., Xiong, Y., Qiu, Z., Ye, D., Guan, K.-L. L2hgdh deficiency accumulates L-2-hydroxyglutarate with progressive leukoencephalopathy and neurodegeneration. Molec. Cell. Biol. 37: e00492-16, 2017. Note: Electronic Article. [PubMed: 28137912] [Full Text: https://doi.org/10.1128/MCB.00492-16]
Najmabadi, H., Hu, H., Garshasbi, M., Zemojtel, T., Abedini, S. S., Chen, W., Hosseini, M., Behjati, F., Haas, S., Jamali, P., Zecha, A., Mohseni, M., and 33 others. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature 478: 57-63, 2011. [PubMed: 21937992] [Full Text: https://doi.org/10.1038/nature10423]
Penderis, J., Calvin, J., Abramson, C., Jakobs, C., Pettitt, L., Binns, M. M., Verhoeven, N. M., O'Driscoll, E., Platt, S. R., Mellersh, C. S. L-2-hydroxyglutaric aciduria: characterisation of the molecular defect in a spontaneous canine model. (Letter) J. Med. Genet. 44: 334-340, 2007. [PubMed: 17475916] [Full Text: https://doi.org/10.1136/jmg.2006.042507]
Rzem, R., Veiga-da-Cunha, M., Noel, G., Goffette, S., Nassogne, M.-C., Tabarki, B., Scholler, C., Marquardt, T., Vikkula, M., Van Schaftingen, E. A gene encoding a putative FAD-dependent L-2-hydroxyglutarate dehydrogenase is mutated in L-2-hydroxyglutaric aciduria. Proc. Nat. Acad. Sci. 101: 16849-16854, 2004. [PubMed: 15548604] [Full Text: https://doi.org/10.1073/pnas.0404840101]
Seijo-Martinez, M., Navarro, C., Castro del Rio, M., Vila, O., Puig, M., Ribes, A., Butron, M. L-2-hydroxyglutaric aciduria: clinical, neuroimaging, and neuropathological findings. Arch. Neurol. 62: 666-670, 2005. [PubMed: 15824270] [Full Text: https://doi.org/10.1001/archneur.62.4.666]
Suhs, K. W., Erdmann, P., Shamdeen, M. G., Papanagiotou, P., Dillmann, U. Adult manifestation of L-2-hydroxyglutarate dehydrogenase deficiency by a novel mutation. Neurology 78: 1186-1187, 2012. [PubMed: 22459673] [Full Text: https://doi.org/10.1212/WNL.0b013e31824f8033]
Topcu, M., Jobard, F., Halliez, S., Coskun, T., Yalcinkayal, C., Gerceker, F. O., Wanders, R. J. A., Prud'homme, J.-F., Lathrop, M., Ozguc, M., Fischer, J. L-2-hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1. Hum. Molec. Genet. 13: 2803-2811, 2004. [PubMed: 15385440] [Full Text: https://doi.org/10.1093/hmg/ddh300]
Wilcken, B., Pitt, J., Heath, D., Walsh, P., Wilson, G., Buchanan, N. L-2-hydroxyglutaric aciduria: three Australian cases. J. Inherit. Metab. Dis. 16: 501-504, 1993. [PubMed: 7609437] [Full Text: https://doi.org/10.1007/BF00711665]